- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2009 (2009), Article ID 278531, 7 pages
Breaching the Blood-Brain Barrier as a Gate to Psychiatric Disorder
1Department of Psychiatry, Soroka University Medical Center; Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
2Department of Physiology and Neurosurgery, Soroka University Medical Center; Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
Received 2 April 2009; Accepted 4 July 2009
Academic Editor: Hari Manev
Copyright © 2009 Hadar Shalev et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- P. Ehrlich, “Das Sauerstoffbeduerfnis des Organismus: Eine Farbenanalytiche Studie,” Hirschwald, vol. 8, p. 167, 1885.
- M. Lewandowsky, “Zur lehre der cerebrospinalflussigkeit,” Zeitschrift Klinische Medizin, vol. 40, pp. 480–494, 1900.
- N. J. Abbott, L. Ronnback, and E. Hansson, “Astrocyte-endothelial interactions at the blood-brain barrier,” Nature Reviews Neuroscience, vol. 7, no. 1, pp. 41–53, 2006.
- W. M. Pardridge, “Blood-brain barrier biology and methodology,” Journal of Neurovirology, vol. 5, no. 6, pp. 556–569, 1999.
- H. Soreq, D. Kaufer, A. Friedman, and C. Glick, “Blood-brain-barrier modulation and low-level exposure to xenobiotics,” pp. 121–144, 2000.
- B. V. Zlokovic, “The blood-brain barrier in health and chronic neurodegenerative disorders,” Neuron, vol. 57, no. 2, pp. 178–201, 2008.
- U. Kniesel and H. Wolburg, “Tight junctions of the blood-brain barrier,” Cellular and Molecular Neurobiology, vol. 20, no. 1, pp. 57–76, 2000.
- H. Wolburg, K. Wolburg-Buchholz, J. Kraus, et al., “Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme,” Acta Neuropathologica, vol. 105, no. 6, pp. 586–592, 2003.
- H. Wolburg and A. Lippoldt, “Tight junctions of the blood-brain barrier: development, composition and regulation,” Vascular Pharmacology, vol. 38, no. 6, pp. 323–337, 2002.
- T. M. Berzin, B. D. Zipser, M. S. Rafii, et al., “Agrin and microvascular damage in Alzheimer's disease,” Neurobiology of Aging, vol. 21, no. 2, pp. 349–355, 2000.
- A. Warth, M. Mittelbronn, and H. Wolburg, “Redistribution of the water channel protein aquaporin-4 and the channel protein Kir4.1 differs in low- and high-grade human brain tumors,” Acta Neuropathologica, vol. 109, no. 4, pp. 418–426, 2005.
- S. Ivens, D. Kaufer, L. P. Flores, et al., “TGF- receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis,” Brain, vol. 130, no. 2, pp. 535–547, 2007.
- E. Seiffert, J. P. Dreier, S. Ivens, et al., “Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex,” Journal of Neuroscience, vol. 24, no. 36, pp. 7829–7836, 2004.
- O. Tomkins, O. Friedman, S. Ivens, et al., “Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex,” Neurobiology of Disease, vol. 25, no. 2, pp. 367–377, 2007.
- E. A. van Vliet, A. S. da Costa, S. Redeker, R. van Schaik, E. Aronica, and J. A. Gorter, “Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy,” Brain, vol. 130, no. 2, pp. 521–534, 2007.
- W. Loscher and H. Potschka, “Drug resistance in brain diseases and the role of drug efflux transporters,” Nature Reviews Neuroscience, vol. 6, no. 8, pp. 591–602, 2005.
- R. Kortekaas, K. L. Leenders, J. C. H. van Oostrom, et al., “Blood-brain barrier dysfunction in parkinsonian midbrain in vivo,” Annals of Neurology, vol. 57, no. 2, pp. 176–179, 2005.
- C. Iadecola, “Neurovascular regulation in the normal brain and in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 5, no. 5, pp. 347–360, 2004.
- M. Schwaninger, S. Sallmann, N. Petersen, et al., “Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-B,” Journal of Neurochemistry, vol. 73, no. 4, pp. 1461–1466, 1999.
- M. A. Deli, L. Descamps, M. P. Dehouck, et al., “Exposure of tumor necrosis factor- to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin,” Journal of Neuroscience Research, vol. 41, no. 6, pp. 717–726, 1995.
- N. Didier, I. A. Romero, C. Créminon, A. Wijkhuisen, J. Grassi, and A. Mabondzo, “Secretion of interleukin-1 by astrocytes mediates endothelin-1 and tumour necrosis factor- effects on human brain microvascular endothelial cell permeability,” Journal of Neurochemistry, vol. 86, no. 1, pp. 246–254, 2003.
- J. D. Huber, R. D. Egleton, and T. P. Davis, “Molecular physiology and pathophysiology of tight junctions in the blood -brain barrier,” Trends in Neurosciences, vol. 24, no. 12, pp. 719–725, 2001.
- Y. Gursoy-Ozdemir, J. Qiu, N. Matsuoka, et al., “Cortical spreading depression activates and upregulates MMP-9,” The Journal of Clinical Investigation, vol. 113, no. 10, pp. 1447–1455, 2004.
- E. Avivi, O. Tomkins, A. Korn, L. Pavlovsky, I. Shelef, and A. Friedman, “Blood-brain-barrier disruption in humans: a window to neurodegenerative diseases,” in Cholinergic Mechanisms, I. Silman, A. Fisher, L. Anglister, D. Michaelson, and H. Soreq, Eds., pp. 423–429, Taylor & Francis, London, UK, 2004.
- N. D. Volkow, B. Rosen, and L. Farde, “Imaging the living human brain: magnetic resonance imaging and positron emission tomography,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 2787–2788, 1997.
- S. Deodhare, P. O'Connor, D. Ghazarian, and J. M. Bilbao, “Paraneoplastic limbic encephalitis in Hodgkin's disease,” Canadian Journal of Neurological Sciences, vol. 23, no. 2, pp. 138–140, 1996.
- P. S. Tofts, G. Brix, D. L. Buckley, et al., “Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols,” Journal of Magnetic Resonance Imaging, vol. 10, pp. 223–232, 1999.
- O. Tomkins, I. Shelef, I. Kaizerman, et al., “Blood-brain barrier disruption in post-traumatic epilepsy,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 7, pp. 774–777, 2008.
- G. Zaharchuk, “Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability,” American Journal of Neuroradiology, vol. 28, no. 10, pp. 1850–1858, 2007.
- N. Marchi, P. Rasmussen, M. Kapural, et al., “Peripheral markers of brain damage and blood-brain barrier dysfunction,” Restorative Neurology and Neuroscience, vol. 21, no. 3-4, pp. 109–121, 2003.
- N. Muller and M. Ackenheil, “Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology,” Schizophrenia Research, vol. 14, no. 3, pp. 223–228, 1995.
- M. J. Schwarz, M. Ackenheil, M. Riedel, and N. Muller, “Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia,” Neuroscience Letters, vol. 253, no. 3, pp. 201–203, 1998.
- P. Gudmundsson, I. Skoog, M. Waern, et al., “The relationship between cerebrospinal fluid biomarkers and depression in elderly women,” American Journal of Geriatric Psychiatry, vol. 15, no. 10, pp. 832–838, 2007.
- I. Skoog, A. Wallin, P. Fredman, et al., “A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia,” Neurology, vol. 50, no. 4, pp. 966–971, 1998.
- S. I. Harik and R. N. Kalaria, “Blood-brain barrier abnormalities in Alzheimer's disease,” Annals of the New York Academy of Sciences, vol. 640, pp. 47–52, 1991.
- R. N. Kalaria, “The blood-brain barrier and cerebral microcirculation in Alzheimer disease,” Cerebrovascular and Brain Metabolism Reviews, vol. 4, no. 3, pp. 226–260, 1992.
- J. Sen and A. Belli, “S100B in neuropathologic states: the CRP of the brain?” Journal of Neuroscience Research, vol. 85, no. 7, pp. 1373–1380, 2007.
- M. Rothermundt, G. Ponath, T. Glaser, G. Hetzel, and V. Arolt, “S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia,” Neuropsychopharmacology, vol. 29, no. 5, pp. 1004–1011, 2004.
- M. L. Schroeter, H. Abdul-Khaliq, M. Krebs, A. Diefenbacher, and I. E. Blasig, “Serum markers support disease-specific glial pathology in major depression,” Journal of Affective Disorders, vol. 111, no. 2-3, pp. 271–280, 2008.
- M. Rothermundt, P. Falkai, G. Ponath, et al., “Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF,” Molecular Psychiatry, vol. 9, no. 10, pp. 897–899, 2004.
- M. Rothermundt, G. Ponath, and V. Arolt, “S100B in schizophrenic psychosis,” International Review of Neurobiology, vol. 59, pp. 445–470, 2004.
- R. F. Haseloff, I. E. Blasig, H. C. Bauer, and H. Bauer, “In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro,” Cellular and Molecular Neurobiology, vol. 25, no. 1, pp. 25–39, 2005.
- A. Friedman, D. Kaufer, and U. Heinemann, “Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy,” Epilepsy Research, vol. 85, no. 2-3, pp. 142–149, 2009.
- S. Fleminger, “Long-term psychiatric disorders after traumatic brain injury,” European Journal of Anaesthesiology, vol. 25, supplement 42, pp. 123–130, 2008.
- D. F. Guerreiro, R. Navarro, M. Silva, M. Carvalho, and C. Gois, “Psychosis secondary to traumatic brain injury,” Brain Injury, vol. 23, no. 4, pp. 358–361, 2009.
- H. S. Sharma and P. K. Dey, “Impairment of blood-brain barrier (BBB) in rat by immobilization stress: role of serotonin (5-HT),” Indian Journal of Physiology and Pharmacology, vol. 25, no. 2, pp. 111–122, 1981.
- A. Friedman, D. Kaufer, J. Shemer, I. Hendler, H. Soreq, and I. Tur-Kaspa, “Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response,” Nature Medicine, vol. 2, no. 12, pp. 1382–1385, 1996.
- P. Esposito, N. Chandler, K. Kandere, et al., “Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress,” Journal of Pharmacology and Experimental Therapeutics, vol. 303, no. 3, pp. 1061–1066, 2002.
- J. Steiner, H. G. Bernstein, H. Bielau, et al., “S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study,” Journal of Psychiatric Research, vol. 42, no. 10, pp. 868–876, 2008.
- R. Dantzer, J. C. O'Connor, G. G. Freund, R. W. Johnson, and K. W. Kelley, “From inflammation to sickness and depression: when the immune system subjugates the brain,” Nature Reviews Neuroscience, vol. 9, no. 1, pp. 46–56, 2008.
- A. H. J. van den Biggelaar, J. Gussekloo, A. J. de Craen, et al., “Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age,” Experimental Gerontology, vol. 42, no. 7, pp. 693–701, 2007.
- J. Wieseler-Frank, S. F. Maier, and L. R. Watkins, “Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences,” Brain, Behavior, and Immunity, vol. 19, no. 2, pp. 104–111, 2005.
- L. McNally, Z. Bhagwagar, and J. Hannestad, “Inflammation, glutamate, and glia in depression: a literature review,” CNS Spectrums, vol. 13, no. 6, pp. 501–510, 2008.
- K. Saito, J. S. Crowley, S. P. Markey, and M. P. Heyes, “A mechanism for increased quinolinic acid formation following acute systemic immune stimulation,” The Journal of Biological Chemistry, vol. 268, no. 21, pp. 15496–15503, 1993.
- R. Wöhrl, S. Eisenach, D. Manahan-Vaughan, U. Heinemann, and D. von Haebler, “Acute and long-term effects of MK-801 on direct cortical input evoked homosynaptic and heterosynaptic plasticity in the CA1 region of the female rat,” European Journal of Neuroscience, vol. 26, no. 10, pp. 2873–2883, 2007.
- T. Rinaldi, C. Perrodin, and H. Markram, “Hyper-connectivity and hyperplasticity in the medial prefrontal cortex in the valproic acid animal model of autism,” Frontiers in Neural Circuits, vol. 2, p. 4, 2008.